Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201310185605N2

Enrollment

Registered

2014-01-16

Start date

2012-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seborrheic dermatitis. Seborrheic dermatitis

Interventions

Intervention 1: In the case group thirty patients received topical sertaconazole 2% cream and were recommended to use the cream twice a day for 4 weeks. Intervention 2: In the control group, 30 patien

Treatment - Drugs

In the case group thirty patients received topical sertaconazole 2% cream and were recommended to use the cream twice a day for 4 weeks.

In the control group, 30 patients received hydrocortisone 1% cream and were recommended to use the cream twice a day for 4 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Sixty patients with seborrheic dermatitis (SD) were studied. Patients who had taken oral corticosteroids; retinoids; antihistamines; or immune-modulating drugs within 28 days before study entery were excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Seborrheic index. Timepoint: 2 weeks. Method of measurement: Clinical assesment.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Goldust Jouybari

Tabriz university of medical sciences

Drmgoldust@yahoo.com+98 41 1545 2206

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026